chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 06/23/2022 in the morning I experienced nasal congestions; fatigue; and elevated body temperature of 99.06. I did a tele health on the same day with my doctor she only gave me vitamins most of them I already took before seeing my doctor.  I started feeling better after 4 days. After 2 months of the vaccine I got hypertension. I went to the doctors office where she increased the dose of my hypertension medication.
CHIEF COMPLAINT/REASON FOR VISIT Fall and Dizziness HISTORY OF PRESENT ILLNESS Patient reports he was back in the bed using his walker and fell onto the ground. He struck his right wrist and elbow, as well as his right side. He denies dizziness prior to the fall felt dizzy once he is picked up by EMS. He denies striking his head, nausea vomiting, change in vision, or focal motor or sensory weakness in his arms or legs. His pain is a 7/10 on his right side. 65-year-old gentleman with past medical history of hypertension, chronic kidney disease status post transplant, and familial tremor presents to the emergency department with right-sided chest wall pain and right arm pain after ground level fall. His trauma imaging revealed multiple acute to subacute right-sided rib fractures as well as a possible radial head fracture of the right elbow. Which he has was consulted regarding the elbow and recommended a sling for 5-6 days with copy of cup weight-bearing and early range of motion. Patient did have significant pain from his rib fractures, requiring multiple doses of IV narcotics as well as erector spinae plane block. He was admitted to TC GS for further respiratory therapy and pain management.
Headache, Aching  from my shoulders to the bottom of my feet,  temperature  low grade 99.8 to 100.5, chills, dizzy, frequent urination every one to two hours starting at 11pm to 7am (urine was clear as water). I had no appetite  and I just didn't feel good.  After 7am the frequent urination  stopped, but  I still had low grade temperature. I receive my vaccine on Saturday, 10/30/21 I didn't feel like myself until  Tuesday, 11/02/21.
Observation of patient after injection of vaccines:     Patient became pale and appeared to go limp. Mother was at her side and guided her to the floor.  Within a few seconds patient opened her eyes. Vital signs were stable throughout the event. Heart  rate: 80s.  Oxygenation: 99%.   Mother reports patient had not eaten any food or had much to drink all day.  She skipped lunch to make the vaccination appointment. It was discussed with mother that events may be due to a vasovagal response.  Patient was given a small snack  and fluids.  Was monitored for 20 more minutes, and was reevaluated by nurse practitioner.   Mother was given ER precautions for any further concerns today.  Will follow up with mother about patient's condition tomorrow.
myocarditis; PVC (premature ventricular contraction); This is a spontaneous report received from a contactable reporter (Other HCP) from medical information team.  A 6 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant), outcome "unknown", described as "myocarditis"; VENTRICULAR EXTRASYSTOLES (medically significant), outcome "unknown", described as "PVC (premature ventricular contraction)". Child that was sent to hospital on Saturday, crushing chest pain, diagnosed with myocarditis and PVC.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on temporal relationship. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate., Linked Report(s) : US-PFIZER INC-202101626263 same reporter and vaccine, different patient and AE
The evening of the vaccine I got a stomach ache. The next day I had low energy, fever, chills, nausea. The morning of the 2nd day I had diarrhea and super achy muscles.
Redness, rash, itchiness, 11/10/16 Primary care Doctor visit. 11/21/10 Second Pri Care Doc visit. Reffered to dermatoglogist. 11/23 first visit. Given cortisone shot and sample cut from back for testing. 11/30 second visit with dermatologist. I was told internal allergic reaction. Given 2nd cortisone shot plus antibiotics.
Tdap inadvertently given instead of DTaP. this was to be his 4th shot in the series. no symptoms at present
Information has been received from an investigator regarding a 2 month old female who received her 1st doses of Prevnar, Hib-Titer, Infanrix, Engerix-B and IPV vaccines on 11/15/01 as part of a post-marketing safety study. On 12/4/01, the infant was seen in an ER where CPR was attempted. Resuscitation was unsuccessful and the infant died. Autopsy results revealed the cause of death as SIDS. The investigator believed the SIDS (expected per package insert) was not related to vaccine administration. The medical monitor's assessment of relatedness is unknown. This report of a serious, labeled event is being submitted in a 15-day time frame, as requested by the FDA. Follow-up info received on 03/12/2002 indicated that the medical monitor agrees with the investigator's assessment that the evnet was not related to vaccine administration. F/U 4/1/02 autopsy states: Pulmonary congestion and edema with mild patchy chronic bronchiolar inflammation; generalized visceral congestion.
15 minutes after receiving the Covid-19 vaccine, patient reported that she was experiencing dizziness and sore throat. She was given Zyrtec 20 mg  and the symptoms resolved shortly thereafter
Case PHEH2016US023371 is an initial spontaneous report received from nurse on 13 Sep 2016. This case refers to  61 year old patient of unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with single dose of FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml intramuscular on left arm on 28 Feb 2015. It was reported that, the patient received FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursion and it was administered to unknown number of patients. No adverse event was reported following this medication error.
eye discharge, bump, knott 2cm x 2.5cm on Lt. Thigh
6-8hr p/vax pt had onset of hives (neck/back);inj site erythema, induration, pain (4x5cm site);malaise, arthralgias, myalgias, nausea, tactile temp,anorexia;difficulty concentrating;erythema, induration @ inj site;
Symptoms Weakness in the arms, and legs. Numbness all over body, left facial droop, blurry vision. It took all of three weeks to take over entire body.  Diagnoses Guillain-Barre Syndrome  Treatment Immunoglobin Gamma Globulin
Patient complained of itching to bilateral cheeks with noted redness following the vaccine. Declined medication (Benadryl IM). No hives noted.
At site of injection a week prior, Shoulder swelling and hot, approx 4" x 4" area. Painful and red.
A 78-years-old male patient (my father) received two doses of mRNA-1273 (Moderna Covid-19 Vaccine) in April 2021.  Medical history included ongoing (managed) hypertension. No acute health issues, no cardiac issues, no family history of cardiac issues, never had COVID-19. Patient does not smoke or drink and leads fairly active lifestyle.   The patient awoke on Monday morning, November 29, 2021 with acute chest and stomach pain, nausea and bowel discomfort. He was rushed to the hospital and diagnosed with type A aortic dissection and emergency open heart surgery was performed to repair the dissection. Outcome: not recovered.  Patient still in ICU. This Type A aortic dissection occurred seven months after vaccination.
Adverse reaction to live FLUMIST. Patient got a spontaneous nosebleed that lasted 15 min at 6 pm. 2nd nosebleed: 7:30 pm. 3rd nosebleed 11 PM, 4th nosebleed 1:30 pm (next day), 5th nosebleed 6:30 pm (10/12/10). It was a warm, humid day. 2 nosebleeds started after after shower. Patient also had fatigue, aches associated with the live FLUMIST.
Fatigue; headache; constipation; then extremely loose stools and 1 event of loss of bowel control.; then extremely loose stools and 1 event of loss of bowel control.; This is a spontaneous report from a contactable Other healthcare professional (patient). A 43-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249), via an unspecified route of administration on 13Jan2021 16:00 at single dose in Left Arm for COVID-19 immunization. The patient medical history was not reported. There were no known allergies. Concomitant medication included escitalopram oxalate (LEXAPRO). There were no other vaccines received in four weeks. The patient did not have COVID-19 prior vaccination and COVID-19 was not tested post vaccination. The patient experienced Fatigue, headache, constipation, then extremely loose stools and 1 event of loss of bowel control on 13Jan2021 17:00, no treatment received for these events. The outcome of the events was unknown.
Ache joints  that continue to get worse every day  and shortness of breath.  If i set idle for a short period of time my knees and hips don't want to move.
17-20 papular rash, 2 with vesicle formation on face, arms, chest, back perueum.
Injection site reaction. Large red circular area at site, swelling, aching. No treatment yet.
I read on an app that DR. has 2 patients who have developed Lupus and after the Pfizer vaccine. He is still studying the cases closely to report them; This is a spontaneous report from a contactable consumer. This consumer reported for patient 2 of 2 patients. A patient of unspecified age and gender received bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The consumer stated that, read on the app that doctor has 2 patients who had developed lupus after the Pfizer vaccine. He was still studying the cases closely to report them. Treatment received for the event was unknown. The seriousness of the reported event was medically significant. The clinical outcome of the event was unknown.  Information about lot/batch number cannot be obtained. Additional information has been requested.
arm became sore; muscle pain; joint pain; fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arm became sore), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm became sore), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (arm became sore), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (fatigue) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided. No concomitant medications were not provided.
Post vax, the pt developed loss of eye contact, no socialization, no language, not responding to his name, and withdrawn. Dx with autism.
The vaccine was administered after the cut-off time on the delivery slip. No symptoms or signs of adverse event reported at the time by the patient.
Bell's Palsy; Pyoderma Gangrenosum; Information has been received from lawyers referring to a male patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not reported.  On or around 31-OCT-2014, the patient was vaccinated with Zoster Vaccine Live (ZOSTAVAX) (strength, dose, frequency, route, lot# and expiration date were unknown) for routine health maintenance and the prevention of shingles (herpes zoster).    On an unknown date, the patient experienced suffered a sudden drooping of the left side of his face as well as numbness in left side of his mouth resulting in diagnosis of Bell's Palsy. The patient also suffered reoccurring blisters of both his hands and was diagnosed with Pyoderma Gangrenosum. The patient did not recover from the events. As per the reporter, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The events were disabling.  The reporter considered the events were related to Zoster Vaccine Live (ZOSTAVAX).  Upon internal review, the events were determined to be medically significant.
Fatigue, headache, fever, chills, hot flashes,  simultaneously hot and cold, insomnia, nausea, body aches
pain at injection site, swollen lymph node in left arm pit, muscle pain L shoulder scapula, fatigue
Swelling; pain at site; Cough; fatigue/tiredness; nausea; fever; pain in all joints; chills; This is a spontaneous report from a contactable consumer or other non hcp. A 72-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 21Jan2021 at 13:00 (at the age of 72 years old) (Batch/Lot Number: EL 9261) as single dose for COVID-19 immunisation. Medical history included many allergies, allergy to Iodine, cscan dye. The patient previously took iodine and experienced iodine allergy. Concomitant medication included duloxetine hydrochloride (CYMBALTA). On 22Jan2021 at 01:00, the patient experienced Swelling, pain at site, Cough, fatigue, nausea, fever, pain in all joints, tiredness and chills. No treatment was received for the adverse events and the reporter considered the events as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
TOOK TWO DOSES OF VIVOTIF WITH FOOD; This spontaneous case report was received from a caregiver (PVX2019-267) on 29-Jan-2019. The report describes a male consumer who "took two doses of Vivotif with food". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  It was reported that the consumer took the second and third dose with breakfast. He completed the full course of Vivotif.   The action taken with Vivotif with respect to the event "took two doses of Vivotif with food" was not applicable.  The clinical outcome of the event "took two doses of Vivotif with food" was unknown.  Company's Comment: The causality of the event "took two doses of Vivotif with food" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses of Vivotif with food" was considered as not applicable.
localized red, swollen, sore, feverish;went to student hlth recv claritan & Ibuprofen & ok in 5-7 days;
1AUg94 pt recvd vax & 1AUG93 PM t102.6; 2AUG t104.6 changed to children's motrin-temp dec to 102.6; temp stayed elevated till 5AUg-on 5AUg pt devel rash;
Pt states that right arm began itching the night immunizations were received (Hep B and MMR). States no rash, itching lasted only one night. She presents on 09/26/00 requesting second Hep B -  not given.
I developed a rash  on my trunk and Back two days after receiving the vaccine. It is 5 days now and the rash continues. Not really responding to Benadryl.  The rash is not raised, is red, and is not really itchy.
Mother calling to on call doctor that pt having a generalized itchy rash. No resp distress or lip swelling. Doctor advised mother to give BENADRYL and call with update in the AM. Mother called in AM - rash gone, pt feeling fine and went to school.
SHE HAD A FEVER AND SWEATING ON THE EVENING THE DAY OF RECEIVING THE SHOT WHICH SHE TREATED WITH IBUPROFEN. CURRENTLY (TWO DAYS AFTER THE IMMUNIZATION), PATIENT REPORTS A VERY SORE RIGHT UPPER ARM WITH  REDNESS, WARMTH, AND PAIN.
Nerve pain; Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a 81-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Shingles) and post herpetic neuralgia (Verbatim: Nerve pain).  The outcome of the shingles was recovered/resolved (duration 2 months) and the outcome of the post herpetic neuralgia was not recovered/not resolved.   The reporter considered the shingles to be possibly related to Shingles vaccine. It was unknown if the reporter considered the post herpetic neuralgia to be related to Shingles vaccine.     The company considered the shingles to be possibly related to Shingles vaccine. It was unknown if the company considered the post herpetic neuralgia to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 04-MAR-2023 This case was reported by a patient via interactive digital media. The patient received first dose of Shingles vaccine then soon after experienced shingles and it was horrible.  Shingles now faded after 2 months. However, the patient still had nerve pain and the patient hope it ends. The patient stated that at 81, it was most awful, and he/she would not wish this to anyone.  The patient thought they got shingles from first shot and was now afraid of receiving the second dose. Follow-up would not possible as no contact details were available.
I had heart palpations on and off and light headed and shortness of breath following the vaccine, symptoms have been ongoing. I received EKG in PCP office which revealed that my heart was having irregular heart rate at times, I was referred to cardiologist to have cardiac event monitor placed.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 12:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 66 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: LEVOTHYROXINE, start date: May1999, stop date: 07Feb2023. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received COVID 19 Treatment with Paxlovid, Treatment start date: 28Jan2023, Treatment stop date: 03Feb2023, Patient had no Known allergies.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
weird taste (bitter) in her mouth; Lymphadenopathy; significant myalgias; injection site soreness; This is a spontaneous report from a contactable physician (patient). A 41-year-old female patient received the second dose of BNT162B2 via an unspecified route of administration on 11Jan2021 at a single dose as Covid vaccine. Medical history and concomitant medications were not reported. The patient previously had her first dose of BNT162B2 on an unspecified date as Covid vaccine. The patient experienced significant myalgias and injection site soreness, both on 11Jan2021; weird taste (bitter) in her mouth and lymphadenopathy, both on 13Jan2021. The patient received her second Covid vaccine on Monday and was having a weird taste in her mouth (weird taste as bitterness). She has significant myalgia that resolved and injection site pain (injection site pain as soreness) that was resolving. She looked it up and could not find anything. She wanted to know if this was something that they were getting a lot of. The outcome of the event significant myalgias was recovered with sequelae on 13Jan2021 while of the rest of events was recovering.  Information on the lot/batch number has been requested.
4cm X 4cm maculopapular, vesicular lesion at injection site, surrounded by 10cm wheal flare consistent with varicella infection.
Initial misuse report received from a healthcare professional on 09 December 2013. This is an invalid case as individual patient identifiers are missing. It was reported that the patient (no information was provided regarding the patients) had received PENTACEL and ACTHIB at the same visit and did not need the forth IPV. No adverse event was reported. Documents held by sender: none.
Patient states his wrist became sore during the administration as he feels it was given on the front of his arm instead of the side (deltoid). Around 3 PM that night his arm became incredibly sore and hard to move.
COVID-19 nasal swab test that was positive; COVID-19 nasal swab test that was positive; Shortness of breath; Angina; chest pain; Fatigue; Diarrhea; Weight loss; Will and desire gone; No appetite; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received BNT162B2 (PFIZER-BINTECH COVID-19 VACCINE), via an unspecified route of administration in right arm, the first dose (Lot Number: EM9809) on 01Mar2021 and the second dose (Lot Number: EN6203) on 22Mar2021 at 13:30 (01:30 PM), both at a single dose, for COVID-19 immunization. The patient's medical history included heart attack, three stents, and diabetes. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 22Mar2021 at 16:00, the patient experienced shortness of breath, angina, fatigue, diarrhea, weight loss, chest pains, will and desire gone, and no appetite. The patient underwent COVID-19 nasal swab test that was negative on 20Mar2021 and positive on 25Mar2021. The patient was hospitalized in Mar2021 for all events for 2 days. It was unknown if treatment was received for the adverse events. The patient had not recovered from the events.
On 10/22/2018 patient was administered another dose of FLUZONE HD. The patient previously received a dose on 09/18/2018.